Hasan Aydede
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hasan Aydede has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Ayça Tan
Manisa Celal Bayar University Faculty of Medicine, Department of Pathology, Manisa, Türkiye
1 shared publication - Can Akcura
Manisa Celal Bayar Üniversitesi
1 shared publication - Enes Kara
Department of Therapy and Rehabilitation, Sakarya University, Vocational School of Health Services, Sakarya, Türkiye
1 shared publication - Eray Kara
Giresun Üniversitesi
1 shared publication Fazilet Uğur Duman
MANİSA CELÂL BAYAR ÜNİVERSİTESİ, TIP FAKÜLTES
1 shared publication- Gamze Gelir Çavdar
Department of Endocrinology and Metabolism, Izmir City Hospital, Izmir, Turkey
1 shared publication
Latest Publications
- 8 March 2025
- Published by Springer Nature in Indian Journal of Surgery
- Vol. 87 (6) , 1053-1058
Are Inflammation Markers Derived from Hemogram Parameters Predictive for Papillary Thyroid Carcinoma in Hashimoto’s Thyroiditis Patients?
- 8 March 2025
- Published by Springer Nature in Indian Journal of Surgery
- Vol. 87 (6) , 1053-1058
Are Inflammation Markers Derived from Hemogram Parameters Predictive for Papillary Thyroid Carcinoma in Hashimoto’s Thyroiditis Patients?
- 30 September 2021
- Published by Celal Bayar Universitesi Saglık Bilimleri Enstitusu Dergisi in Celal Bayar Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi
- Vol. 8 (3) , 419-425
Tiroid papiller karsinom, papiller mikrokarsinom ve tiroid papiller karsinomun lenf nodu metastazında apoptoz ve hücre siklusu ile ilişkili belirleyicilerin (p16, p2l, p27, p53, bcl-2, bax, bcl-xl ve siklin-D1) doku microarray yöntemiyle saptanması
AObjective: The aim of this study was to identify the role of apoptosis and cell cycle associated gene products in the pathogenesis of thyroid papillary carcinoma (TPC) and its lymph node metastasis. Materials and Methods: Cases of thyroid papillary carcinoma (n=35), thyroid papillary microcarcinoma (TPMC) (n=22), TPC-lymph node metastasis (TPC-LNM) (n=12), and adenomatous nodule (AN) (n=20) were examined using tissue microarray method (TMA) by immunohistochemistry staining for p16, p21, p27, p53, bcl-2, bax, bcl-xL and cyclin D1. Results: Bcl-2 staining of the ANs was significantly differed from those of malignant groups. p53, p16, p21 staining percentages were significantly higher in the malignant groups than in the benign lesions. TPC-LNM group had higher p16 and cyclin D1 positivity than the primary tumor groups. The most remarkable difference of p27 staining was between the TPC-LNM and TPC groups. Conclusion: We concluded that cell cycle regulators, especially bcl-2 family, play important roles in TPC carcinogenesis. The cyclin-dependent kinase inhibitors acting on the cyclin-CDK complex (p16, p21, p27) were more associated with potential for malignancy, progression and poor prognosis. p53 plays an important role in the TPC pathogenesis by interacting with the proteins regulating both apoptosis and the cell cycle.
- 30 September 2021
- Published by Celal Bayar Universitesi Saglık Bilimleri Enstitusu Dergisi in Celal Bayar Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi
- Vol. 8 (3) , 419-425
Tiroid papiller karsinom, papiller mikrokarsinom ve tiroid papiller karsinomun lenf nodu metastazında apoptoz ve hücre siklusu ile ilişkili belirleyicilerin (p16, p2l, p27, p53, bcl-2, bax, bcl-xl ve siklin-D1) doku microarray yöntemiyle saptanması
AObjective: The aim of this study was to identify the role of apoptosis and cell cycle associated gene products in the pathogenesis of thyroid papillary carcinoma (TPC) and its lymph node metastasis. Materials and Methods: Cases of thyroid papillary carcinoma (n=35), thyroid papillary microcarcinoma (TPMC) (n=22), TPC-lymph node metastasis (TPC-LNM) (n=12), and adenomatous nodule (AN) (n=20) were examined using tissue microarray method (TMA) by immunohistochemistry staining for p16, p21, p27, p53, bcl-2, bax, bcl-xL and cyclin D1. Results: Bcl-2 staining of the ANs was significantly differed from those of malignant groups. p53, p16, p21 staining percentages were significantly higher in the malignant groups than in the benign lesions. TPC-LNM group had higher p16 and cyclin D1 positivity than the primary tumor groups. The most remarkable difference of p27 staining was between the TPC-LNM and TPC groups. Conclusion: We concluded that cell cycle regulators, especially bcl-2 family, play important roles in TPC carcinogenesis. The cyclin-dependent kinase inhibitors acting on the cyclin-CDK complex (p16, p21, p27) were more associated with potential for malignancy, progression and poor prognosis. p53 plays an important role in the TPC pathogenesis by interacting with the proteins regulating both apoptosis and the cell cycle.
- 1 February 2020
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 46 (2) , e85
Synchronous Multivisceral Resections in Metastatic or Locally Advanced Gastrointestinal Cancers
- 1 February 2020
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 46 (2) , e85
Synchronous Multivisceral Resections in Metastatic or Locally Advanced Gastrointestinal Cancers
- 1 September 2016
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 42 (9) , S140
278. Synchronous multivisceral resections in metastatic or locally advanced cancers: Early results of one centre
- 1 September 2016
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 42 (9) , S140
278. Synchronous multivisceral resections in metastatic or locally advanced cancers: Early results of one centre
- 1 January 2009
- Published by Elsevier in Acta Histochemica
- Vol. 111 (1) , 74-82
Effects of ocreotide on intestinal mucosa in rats with portal hypertensive enteropathy
- 1 January 2009
- Published by Elsevier in Acta Histochemica
- Vol. 111 (1) , 74-82
Effects of ocreotide on intestinal mucosa in rats with portal hypertensive enteropathy